PICO Portalanswers from OpenAlex

Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy

PaperCitations, authors & open-access status

Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy is a paper indexed in PICO Portal from OpenAlex.

How many citations does Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy have?

PICO Portalcitation count

Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy has 59 citations in the OpenAlex counts PICO Portal stores.

When was Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy published?

PICO Portalyear

Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy has 2019 year in the PICO Portal index.

Open the OpenAlex record →

What is the open-access status of Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy?

PICO Portaloa status

Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy has closed oa status in the PICO Portal index.

Open the OpenAlex record →

What is the DOI of Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy?

PICO Portaldoi

The DOI for Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy is on the source record.

Open the DOI →

What is the PMID of Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy?

PICO Portalpmid

The PMID for Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy is on the source record.

Open the PMID →

What is the OpenAlex record for Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy?

PICO Portalopenalex

The OpenAlex for Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy is on the source record.

Open the OpenAlex →

Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis <i>via</i> CD36/β-Catenin Pathway in Diabetic Nephropathy

How many citations does Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis <i>via</i> CD36/β-Catenin Pathway in Diabetic Nephropathy have?

When was Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis <i>via</i> CD36/β-Catenin Pathway in Diabetic Nephropathy published?

What is the open-access status of Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis <i>via</i> CD36/β-Catenin Pathway in Diabetic Nephropathy?

What is the DOI of Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis <i>via</i> CD36/β-Catenin Pathway in Diabetic Nephropathy?

What is the PMID of Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis <i>via</i> CD36/β-Catenin Pathway in Diabetic Nephropathy?

What is the OpenAlex record for Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis <i>via</i> CD36/β-Catenin Pathway in Diabetic Nephropathy?

Related on PICO Portal